Drug Database
Back to search

Netherlands· NL-78b492f9b5e7

Actraphane 30 InnoLet 100 internationale eenheden/ml suspensie voor injectie in voorgevulde pen

A insulin (human) product containing insuline humaan + insuline isofaan, humaan, registered in Netherlands by Novo Nordisk A.S.. The same ATC class is registered in 9 of our 19 countries.

ATC A10AD01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedActraphane 30 InnoLet 100 internation…ATCA10AD01REGISTER NO.NL-78b492f9b5e7PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about insuline humaan + insuline isofaan, humaanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Insulin (human) is registered in 9 of 19 countries.

Countries holding a registration under ATC A10AD01 (insulin (human)), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search insulin (human) products by name

Insulin (human) · ATC A10AD01

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
INSULINE HUMAAN + INSULINE ISOFAAN, HUMAAN
Manufacturer
Novo Nordisk A.S.
Country
Netherlands (NL)
ATC code
A10AD01
ATC class
Insulin (human)
Defined daily dose
40 E, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/02/229

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

461 interactions on record for insulin (human).

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check insulin (human) against other medicinesHow interaction checks work

Insulin (human) · interactions on record

461 records

  • 15 severe
  • 395 moderate
  • 50 minor

Most severe, free to view

  • SucralfateA02BX02moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • PrednisoloneA07EA01moderate

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under A10AD01

Insulin (human), as other registers publish it.

All insulin (human) products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c6b1d076-1af3-4766-b07a-1785b8ff3d6f
GET /v1/drugs/c6b1d076-1af3-4766-b07a-1785b8ff3d6f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor injectie",
  "route": "Subcutaan gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/actraphane-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Insulin (Human)",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp72661",
  "excipients": [
    "DINATRIUMWATERSTOFFOSFAAT 2-WATER (E 339)",
    "FENOL",
    "GLYCEROL (E 422)",
    "METACRESOL",
    "NATRIUMHYDROXIDE (E 524)",
    "PROTAMINESULFAAT",
    "WATER VOOR INJECTIE",
    "ZINKDICHLORIDE (BEREID UIT ZINKOXIDE EN ZOUTZUUR)",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "INSULINE HUMAAN",
    "INSULINE ISOFAAN, HUMAAN"
  ],
  "leaflet_url": null,
  "authorised_at": "2002/10/07",
  "procedure_number": "EMEA/H/C/000427",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/02/229",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about insulin (human).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console